The Swedish pharmacy market is undergoing a rapid transformation towards e-commerce. The pandemic has accelerated the change and during the first half of 2021, e-commerce’s share reached 18% of all sales in the pharmacy market in Sweden. To support the growth of e-commerce, Oriola is investing in a new warehouse for e-commerce operations in Enköping, Sweden. The new warehouse will deliver online orders to consumer customers in the pharmacy chain Kronans Apotek, which Oriola owns.
“Our e-commerce grew by 85% in 2020 and the plan is to continue rapid expansion. To become one of the best players in e-commerce in the pharmacy market, we must increase the capacity of our e-commerce warehouse. Investments will also make it possible for us to create even better flows and processes to optimize e-commerce and support its profitable development “, says Elisa Markula, President and CEO of Oriola and interim manager of Business Area Consumer.
The e-commerce warehouse is currently located in Oriola’s distribution center in Enköping. The new e-commerce warehouse frees up capacity for Oriola’s other distribution operations and covers approximately 15,000 square meters with the opportunity to expand. Oriola leases the facility from Logicenters. The construction project will start in the autumn of 2021 and the new e-commerce warehouse will be ready during the second half of 2022. The warehouse will be built according to BREEAM’s sustainability model and certifications to ensure the best possible environmental performance.
VP, communication and sustainability
Tel. +358 40 5885 343
Email: [email protected]
Oriola is a health and wellness company operating in the Nordic countries. We help people live a healthier life by giving them access to sustainable health and well-being products and services. In Sweden, Oriola owns the country’s third largest pharmacy chain, Kronans Apotek. In addition to pharmacies, our dose distribution, medical information and patient support safety improve the safety and effectiveness of pharmaceutical care. Our expert services support pharmaceutical companies throughout the life cycle of the drug. Oriola’s supply chain ensures reliable and secure delivery of medicines to pharmacies, hospital pharmacies, veterinarians and other healthcare operators. In 2020, Oriola Corporation’s turnover was EUR 1.8 billion and we employed approximately 4,300 professionals. Oriola Corporation is listed on Nasdaq Helsinki. www.oriola.com
Oriola Oyj published this content on September 27, 2021 and is solely responsible for the information in it. Delivered by public, unedited and unchanged, on 27 September 2021 06:21:05 UTC.